Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients
Yajian Wang, Haijing Liu, Yingyong Hou, Xiaoyan Zhou, Li Liang, Zhihong Zhang, Huaiyin Shi, Sanpeng Xu, Peizhen Hu, Zuyu Zheng, Rui Liu, Tingdong Tang, Feng Ye, Zhiyong Liang, Hong Bu (2018). Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients. Virchows Archiv, 472(6), pp. 959-968, DOI: 10.1007/s00428-018-2359-4.
Article191 days agoIcotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
Jianxing He, Chunxia Su, Wenhua Liang, Shidong Xu, Lin Wu, Xiangning Fu, Xu Dong Zhang, Di Ge, Qun Chen, Weimin Mao, Lin Xu, Chun Chen, Bing Hu, Guoguang Shao, Jian Hu, Jian Zhao, Xiaoqing Liu, Zhidong Liu, Zheng Wang, Zemin Xiao, Taiqian Gong, Wen Lin, Xingya Li, Feng Ye, Yang Liu, Haitao Ma, Yunchao Huang, Jianying Zhou, Zhong Lin Wang, Junke Fu, Lieming Ding, Li Mao, Caicun Zhou (2021). Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial. , 9(9), DOI: https://doi.org/10.1016/s2213-2600(21)00134-x.
Article145 days agoAuthor Correction: HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Feng Ye, Ying Chen, ThaoNguyen Hoang, Rusty L. Montgomery, Xian-hui Zhao, Hong Bu, Tom C. Hu, Makoto M. Taketo, Johan H. van Es, Hans Clevers, Jenny Hsieh, Rhonda Bassel‐Duby, Eric N. Olson, Q. Richard Lu (2025). Author Correction: HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction. , 28 (8), DOI: https://doi.org/10.1038/s41593-025-02034-w.
Corrigendum3 days ago